DK2813512T3 - Fremgangsmåde til cyklisering af en peptidforbindelse - Google Patents

Fremgangsmåde til cyklisering af en peptidforbindelse Download PDF

Info

Publication number
DK2813512T3
DK2813512T3 DK12861199.3T DK12861199T DK2813512T3 DK 2813512 T3 DK2813512 T3 DK 2813512T3 DK 12861199 T DK12861199 T DK 12861199T DK 2813512 T3 DK2813512 T3 DK 2813512T3
Authority
DK
Denmark
Prior art keywords
cyclizing
procedure
peptide connection
peptide
connection
Prior art date
Application number
DK12861199.3T
Other languages
English (en)
Inventor
Shiori Kariyuki
Takeo Iida
Miki Kojima
Ryuichi Takeyama
Mikimasa Tanada
Tetsuo Kojima
Hitoshi Iikura
Atsushi Matsuo
Takuya Shiraishi
Takashi Emura
Kazuhiko Nakano
Koji Takano
Kousuke Asou
Takuya Torizawa
Ryusuke Takano
Nozomi Hisada
Naoaki Murao
Atsushi Ohta
Kaori Kimura
Yusuke Yamagishi
Tatsuya Kato
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK2813512T3 publication Critical patent/DK2813512T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK12861199.3T 2011-12-28 2012-12-28 Fremgangsmåde til cyklisering af en peptidforbindelse DK2813512T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011288865 2011-12-28
JP2012156943 2012-07-12
PCT/JP2012/084103 WO2013100132A1 (ja) 2011-12-28 2012-12-28 ペプチド化合物の環化方法

Publications (1)

Publication Number Publication Date
DK2813512T3 true DK2813512T3 (da) 2021-04-26

Family

ID=48697609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12861199.3T DK2813512T3 (da) 2011-12-28 2012-12-28 Fremgangsmåde til cyklisering af en peptidforbindelse

Country Status (7)

Country Link
US (4) US9409952B2 (da)
EP (2) EP2813512B1 (da)
JP (6) JP6294080B2 (da)
DK (1) DK2813512T3 (da)
HU (1) HUE054006T2 (da)
TW (6) TWI640541B (da)
WO (1) WO2013100132A1 (da)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI640541B (zh) 2011-12-28 2018-11-11 中外製藥股份有限公司 Peptide compound having an annular portion and pharmaceutical composition thereof
US10815489B2 (en) 2015-03-13 2020-10-27 Chugai Seiyaku Kabushiki Kaisha Modified aminoacyl-tRNA synthetase and use thereof
US20160367961A1 (en) * 2015-04-23 2016-12-22 Roche Sequencing Solutions, Inc. Method and composition for peptide cyclization and protease treatment
US10011631B2 (en) * 2015-12-01 2018-07-03 The University Of Hong Kong Stapled helical peptides and methods of synthesis
WO2017150732A1 (ja) * 2016-03-03 2017-09-08 中外製薬株式会社 チオール基をアミノ基近傍に有するアミノ酸をn末端に持つ非環状ペプチド-核酸複合体、そのライブラリー、およびそれから誘導される環状ペプチド-核酸複合体ライブラリーの製造方法
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
CA3044645A1 (en) * 2016-12-09 2018-06-14 Fujifilm Corporation Mixed mode affinity chromatography carrier
WO2018124162A1 (ja) * 2016-12-28 2018-07-05 中外製薬株式会社 化合物の膜透過性を改善するための自己乳化型製剤
US12391971B2 (en) 2017-01-31 2025-08-19 Chugai Seiyaku Kabushiki Kaisha Method for synthesizing peptides in cell-free translation system
WO2018201050A1 (en) * 2017-04-28 2018-11-01 Board Of Trustees Of Michigan State University Tryptathionine biosynthesis by flavin mono-oxygenase 1 (fmo1)
EP3623378B1 (en) 2017-05-12 2025-07-02 Chugai Seiyaku Kabushiki Kaisha Method for producing cyclic organic compound
KR20250007021A (ko) 2017-06-09 2025-01-13 추가이 세이야쿠 가부시키가이샤 N-치환 아미노산을 포함하는 펩타이드의 합성 방법
US20200131669A1 (en) * 2017-06-09 2020-04-30 Chugai Seiyaku Kabushiki Kaisha Cyclic peptide compound having high membrane permeability, and library containing same
CN110933946A (zh) * 2017-07-20 2020-03-27 百时美施贵宝公司 用于制备N-((1R,2S,5R)-5-(叔丁基氨基)-2-((S)-3-(7-叔丁基吡唑并[1,5-a][1,3,5]三嗪-4-基氨基)-2-氧代吡咯烷-1-基)环己基)乙酰胺的方法
CN111479819B (zh) 2017-12-15 2024-06-14 中外制药株式会社 制备肽的方法和处理碱的方法
US11814621B2 (en) 2018-06-01 2023-11-14 Northwestern University Expanding the chemical substrates for genetic code reprogramming
US12493033B2 (en) 2018-06-04 2025-12-09 Chugai Seiyaku Kabushiki Kaisha Method for detecting bi-specific antibody complex
WO2019235581A1 (ja) 2018-06-06 2019-12-12 国立大学法人大阪大学 Regnase-1が関与する疾患の治療および/または予防方法
EP3613757A1 (en) * 2018-08-20 2020-02-26 Wntresearch AB Solution phase routes for wnt hexapeptides
WO2020057592A1 (en) * 2018-09-20 2020-03-26 The University Of Hong Kong Beta-lactam compounds and methods of use thereof
EP3878836B1 (en) 2018-11-07 2025-07-23 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
WO2020111238A1 (ja) 2018-11-30 2020-06-04 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
CN118184532A (zh) 2018-12-12 2024-06-14 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法
WO2020138336A1 (ja) 2018-12-26 2020-07-02 中外製薬株式会社 コドン拡張のための変異tRNA
JP7495420B2 (ja) 2019-02-20 2024-06-04 ノヴォ ノルディスク アー/エス アミノアシル-tRNA合成酵素およびこの使用
CN109824622B (zh) * 2019-02-27 2022-12-30 中国科学技术大学 一类细胞内形成纳米结构杀死癌细胞的前体药物及其制法
CN113692401A (zh) 2019-03-15 2021-11-23 中外制药株式会社 芳香族氨基酸衍生物的制备方法
EP3978018A4 (en) 2019-05-31 2023-07-19 Osaka University Novel therapeutic agent for digestive organ cancer, and screening method for same
EP4043076B1 (en) 2019-10-08 2024-06-26 GeneFrontier Corporation Cyclic peptide having ctla-4 inhibitory activity and use thereof
JP6880352B1 (ja) * 2019-11-07 2021-06-02 中外製薬株式会社 Kras阻害作用を有する環状ペプチド化合物
EP4056580A4 (en) 2019-11-07 2023-12-06 Chugai Seiyaku Kabushiki Kaisha METHOD FOR PRODUCING A PEPTIDE COMPOUND COMPRISING A STERICALLY HINDERED AMINO ACID
WO2021117848A1 (ja) 2019-12-12 2021-06-17 中外製薬株式会社 非天然アミノ酸を含むペプチドの製造方法
KR20220121831A (ko) 2019-12-26 2022-09-01 추가이 세이야쿠 가부시키가이샤 번역용 조성물 및 펩타이드의 제조 방법
TW202210498A (zh) 2020-06-03 2022-03-16 日商中外製藥股份有限公司 高難度序列之有效率的胜肽縮合法
JPWO2021261577A1 (da) 2020-06-25 2021-12-30
IL301342A (en) * 2020-10-21 2023-05-01 Provincial Health Services Authority Novel CXCR4-targeting compounds
TW202229306A (zh) 2020-11-05 2022-08-01 日商中外製藥股份有限公司 抑制由二酮哌嗪形成所導致之缺陷的胜肽合成方法
WO2022138891A1 (ja) 2020-12-25 2022-06-30 中外製薬株式会社 N-置換-アミノ酸残基を含むペプチド化合物の製造方法
EP4257978A4 (en) 2020-12-25 2024-11-13 Chugai Seiyaku Kabushiki Kaisha METHOD FOR SCREENING CANDIDATE MOLECULES CAPABLE OF FORMING A COMPLEX IN CONJUNCTION WITH MULTIPLE TARGET MOLECULES
CN116547295A (zh) 2020-12-28 2023-08-04 中外制药株式会社 氨基酸向固相合成用树脂的担载方法
WO2022173627A2 (en) * 2021-02-02 2022-08-18 Northwestern University Ribosome-mediated polymerization of novel chemistries
AU2022269959A1 (en) 2021-05-07 2023-11-16 Chugai Seiyaku Kabushiki Kaisha Methods for producing cyclic compounds comprising N-substituted amino acid residues
WO2022234639A1 (ja) 2021-05-07 2022-11-10 中外製薬株式会社 変異型ras(g12d)に対する選択的結合性を示す結合分子
AR125800A1 (es) 2021-05-07 2023-08-16 Chugai Pharmaceutical Co Ltd Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n
EP4299069A4 (en) 2021-05-07 2025-03-05 Chugai Seiyaku Kabushiki Kaisha Preparation containing cyclic peptide compound and method for producing same
CN117279933A (zh) 2021-05-07 2023-12-22 中外制药株式会社 相对于hras和nras具有选择性kras抑制作用的环状化合物
KR102666765B1 (ko) 2021-05-07 2024-05-16 추가이 세이야쿠 가부시키가이샤 환상 펩타이드 화합물의 의약 용도
JPWO2023054636A1 (da) 2021-09-30 2023-04-06
KR20240070705A (ko) 2021-10-13 2024-05-21 추가이 세이야쿠 가부시키가이샤 펩타이드 화합물 및 계면활성제를 포함하는 조성물
IL313756A (en) * 2021-12-24 2024-08-01 Sentcell Ltd Inhibitors of the sestrin-MAPK complex
WO2023190283A1 (ja) 2022-03-28 2023-10-05 中外製薬株式会社 ポリオキシエチレン構造を含む油性成分を含有する化合物製剤
WO2023195516A1 (ja) 2022-04-08 2023-10-12 中外製薬株式会社 ペプチド化合物の製造方法
KR20250006193A (ko) 2022-05-02 2025-01-10 추가이 세이야쿠 가부시키가이샤 디케토피페라진 형성에 의한 결손을 억제하는 펩티드 합성 방법
KR20250002095A (ko) 2022-05-02 2025-01-07 추가이 세이야쿠 가부시키가이샤 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물
AU2023264918A1 (en) 2022-05-06 2025-01-09 Chugai Seiyaku Kabushiki Kaisha Cyclic compound having selective kras inhibitory effect on hras and nras
US20260015313A1 (en) 2022-06-03 2026-01-15 Peptidream Inc. Amino acid active ester and salt thereof
CN115286671B (zh) * 2022-07-13 2023-06-23 康龙化成(宁波)科技发展有限公司 一种寡聚核酸-噻唑烷类化合物、合成方法、应用
WO2024024965A1 (ja) 2022-07-29 2024-02-01 中外製薬株式会社 O-置換セリン誘導体の製造方法
TW202417465A (zh) * 2022-08-23 2024-05-01 日商富士軟片股份有限公司 環肽或其鹽及mdmx抑制劑
TW202417032A (zh) 2022-08-23 2024-05-01 日商富士軟片股份有限公司 環肽或其鹽及mdmx抑制劑
WO2024043251A1 (ja) 2022-08-23 2024-02-29 富士フイルム株式会社 環状ペプチドの細胞膜透過性の予測方法
WO2024073568A2 (en) * 2022-09-28 2024-04-04 President And Fellows Of Harvard College Evolution of fluorogenic sensors
TW202430537A (zh) 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法
TW202432571A (zh) 2022-11-01 2024-08-16 日商中外製藥股份有限公司 二苯并富烯或二苯并富烯衍生物的去除方法
JPWO2024101386A1 (da) 2022-11-09 2024-05-16
KR20240082196A (ko) 2022-11-09 2024-06-10 추가이 세이야쿠 가부시키가이샤 Hras 및 nras에 대해서 선택적인 kras 저해 작용을 갖는 환상 화합물을 포함하는 의약 조성물
WO2024101402A1 (ja) 2022-11-09 2024-05-16 中外製薬株式会社 Hrasおよびnrasに対して選択的なkras阻害作用を有する環状化合物を含む医薬組成物
KR20250124834A (ko) 2022-12-12 2025-08-20 추가이 세이야쿠 가부시키가이샤 특정 위치에 산소 원자를 갖는 아미노산을 번역하는 단계를 포함하는 펩타이드의 제조 방법
WO2024126687A1 (en) * 2022-12-16 2024-06-20 Silence Therapeutics Gmbh Nucleic acids conjugated to an albumin binding moiety
CN120418263A (zh) 2022-12-28 2025-08-01 中外制药株式会社 环肽的纯化方法和生产方法
WO2024151615A1 (en) * 2023-01-10 2024-07-18 The University Of North Carolina At Chapel Hill Mrna display libraries and methods of use
EP4663653A1 (en) 2023-03-20 2025-12-17 Chugai Seiyaku Kabushiki Kaisha Method for producing eutectic of cyclic peptide
WO2024209857A1 (ja) * 2023-04-03 2024-10-10 富士フイルム株式会社 核酸ディスプレイライブラリの作製方法、スクリーニング方法、及びポリペプチドの作製方法
WO2024214303A1 (ja) 2023-04-14 2024-10-17 中外製薬株式会社 複数種類の標的分子との複合体を形成し得る目的分子のスクリーニング方法、及び当該スクリーニング方法を含む目的分子の製造方法
CN120897751A (zh) 2023-04-19 2025-11-04 中外制药株式会社 含有环肽化合物和表面活性剂的组合物
WO2024263911A2 (en) * 2023-06-22 2024-12-26 Dana-Farber Cancer Institute, Inc. Methods for the synthesis and linearization of peptidomimetic macrocycles
CN121532404A (zh) 2023-09-28 2026-02-13 中外制药株式会社 用于使用混合酸酐程序生产肽化合物的方法
WO2025079184A1 (ja) 2023-10-11 2025-04-17 中外製薬株式会社 複数のライブラリを用いたペプチドのスクリーニング方法
WO2025100405A1 (ja) 2023-11-06 2025-05-15 中外製薬株式会社 細胞膜透過性と代謝安定性を有する大環状ペプチド化合物、及びこれを含むライブラリ
WO2025143077A1 (ja) 2023-12-27 2025-07-03 中外製薬株式会社 スタンドアローン型縮合剤を用いたペプチド化合物の製造方法
WO2025226861A1 (en) * 2024-04-24 2025-10-30 Circle Pharma, Inc. Cyclin inhibitors
CN119455452B (zh) * 2024-10-16 2026-04-28 国电投核素同创(重庆)科技有限公司 一种通过辐照钍靶生产Ac-225母液的方法
CN119708146B (zh) * 2024-12-30 2026-03-17 五邑大学 一种环肽Lagunamide D的制备方法

Family Cites Families (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159747A (en) 1981-03-27 1982-10-01 Kenji Okawa Synthesis of amino acid derivative
JPS60169451A (ja) 1984-02-13 1985-09-02 Mitsui Toatsu Chem Inc L−フエニルアラニンの分離精製法
FR2583432B1 (fr) 1985-06-13 1988-11-04 Inst Francais Du Petrole Procede de production enzymatique de l-a-aminoacides a partir d'a-cetoacides
ES8607214A1 (es) 1985-10-16 1986-06-01 Gema Sa Procedimiento enzimatico de resolucion de n-fenilacetil-ami-nocompuestos y purificacion de sus isomeros opticamente ac- tivos
US4859736A (en) 1987-03-30 1989-08-22 Ciba-Geigy Corporation Synthetic polystyrene resin and its use in solid phase peptide synthesis
DE3733198A1 (de) 1987-10-01 1989-04-13 Kernforschungsanlage Juelich Enzymatisches verfahren zur herstellung von dipeptiden
JPH0681759B2 (ja) 1988-03-31 1994-10-19 信越化学工業株式会社 ポリペプチドの製造方法
GB9022788D0 (en) 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US7045363B2 (en) * 1996-05-01 2006-05-16 Fujirebio Inc. Nucleic acid-bound polypeptide method of producing nucleic acid-bound polypeptide and immunoassay using the polypeptide
DK0971946T3 (da) * 1997-01-21 2006-10-30 Gen Hospital Corp Selektion af proteiner ved anvendelse af RNA-protein-fusioner
US20020068301A1 (en) 1997-05-28 2002-06-06 Hung-Sen Lai Cyclic peptide libraries and methods of use thereof to identify binding motifs
WO1998056381A1 (en) 1997-06-09 1998-12-17 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
PT1123084E (pt) 1998-10-02 2005-05-31 Schering Ag Utilizacao de esteres de testosterona e/ou testosterona para a preparacao de sistemas bioadesivos aplicaveis por via bucal com agentes activos medicamentosos de accao retardada
US6977083B1 (en) 1998-10-02 2005-12-20 Jenapharm Gmbh & Co. Kg Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
US6057289A (en) 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
JP4502293B2 (ja) 1999-06-04 2010-07-14 長瀬産業株式会社 軸不斉を有する光学活性な4級アンモニウム塩、その製法およびα−アミノ酸誘導体の不斉合成への応用
DE19942624A1 (de) * 1999-08-28 2001-03-08 Chemotopix Gmbh Verfahren zur Herstellung von zyklischen Peptidomimetika
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0001449D0 (en) 2000-01-21 2000-03-08 Cortendo Ab Compositions
NZ521456A (en) 2000-04-19 2004-07-30 Schering Corp Macrocyclic NS3-Serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
EP1277755A4 (en) 2000-04-21 2006-01-11 Nagase & Co Ltd OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT BY AXIAL ASYMMETRY, METHOD FOR THE PRODUCTION THEREOF, AND THEIR APPLICATION IN THE ASYMMETRIC SYNTHESIS OF ALPHA-AMINO-ACID DERIVATIVES
KR100401296B1 (ko) * 2000-12-27 2003-10-11 드림바이오젠 주식회사 수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
JP4061043B2 (ja) 2000-12-28 2008-03-12 株式会社ポストゲノム研究所 invitro転写/翻訳系によるペプチド等の製造方法
IL158418A0 (en) 2001-04-19 2004-05-12 Scripps Research Inst In vivo incorporation of unnatural amino acids
CA2452818C (en) 2001-08-01 2010-06-29 Japan Science And Technology Agency Tyrosyl-trna synthetase variants
US7288372B2 (en) 2002-01-17 2007-10-30 Ambergen, Inc. Methods for the preparation of chemically misaminoacylated tRNA via protective groups
AU2003225085A1 (en) 2002-04-19 2003-11-03 California Institute Of Technology Unnatural amino acid containing display libraries
US7385038B2 (en) * 2002-07-18 2008-06-10 Protein Express Co., Ltd. Non-natural labeled amino acid and method of constructing amino acid/tRNA complex
JP4490663B2 (ja) 2003-09-22 2010-06-30 株式会社東京大学Tlo イソロイシンtRNA(tRNAIle)のライシジン合成酵素(TilS)としてのmesJ遺伝子産物及びその相同性遺伝子(COG0037)
ATE376556T1 (de) 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
EP1725250A2 (en) 2004-02-18 2006-11-29 Frutarom Ltd. Method for the preparation of peptide-oligonucleotide conjugates
KR20070084531A (ko) 2004-11-24 2007-08-24 머크 앤드 캄파니 인코포레이티드 치환된 아미드의 경구 투여용 액체 및 반고체 약제학적제형
WO2007066627A1 (ja) 2005-12-06 2007-06-14 The University Of Tokyo 多目的アシル化触媒とその用途
EP1999259B1 (en) 2006-03-03 2014-06-25 California Institute of Technology Site-specific incorporation of amino acids into molecules
US8754192B2 (en) 2006-04-11 2014-06-17 Sloan-Kettering Institute For Cancer Research Compositions comprising homogeneously glycosylated erythropoietin
JP2007319064A (ja) 2006-05-31 2007-12-13 Japan Science & Technology Agency 修飾化アミノ酸を部位特異的に導入したタンパク質を発現させる方法
JP5200241B2 (ja) 2006-11-17 2013-06-05 国立大学法人 東京大学 N末端に非天然骨格をもつポリペプチドの翻訳合成とその応用
US9090668B2 (en) 2007-03-26 2015-07-28 The University Of Tokyo Process for synthesizing cyclic peptide compound
JP2009096791A (ja) 2007-09-26 2009-05-07 Kaneka Corp アミノ酸の製造方法
EA201070483A1 (ru) 2007-10-16 2010-10-29 Сан Фарма Адвансед Ресьёрч Компани Лимитед Новые офтальмологические композиции
EP2177533A1 (en) 2008-10-09 2010-04-21 TU München Multiple N-methylated cyclic hexapeptides for treatment of neurogenic inflammation
TWI468375B (zh) 2008-10-27 2015-01-11 Janssen Pharmaceutica Nv 製備經保護之l-丙胺酸衍生物之方法
WO2010053050A1 (ja) 2008-11-04 2010-05-14 株式会社カネカ O-アルキルセリンおよびn-ベンジル-o-アルキルセリンの製造法
CN102239176A (zh) 2008-12-03 2011-11-09 弗·哈夫曼-拉罗切有限公司 用于制备治疗性肽的方法
EP2424888A2 (en) 2009-05-01 2012-03-07 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
EP2492344B1 (en) 2009-10-22 2016-04-06 PeptiDream Inc. Rapid display method in translational synthesis of peptide
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds
US20110118314A1 (en) 2009-11-16 2011-05-19 Weiya Yun Piperidine analogs as glycogen synthase activators
JP2011139667A (ja) 2010-01-07 2011-07-21 Tottori Univ プロリンおよびβ−アラニンをN末端に有するジペプチド、及びその環化ジペプチドの酵素合成法
EP2523655A2 (en) 2010-01-12 2012-11-21 Novo Nordisk A/S Pharmaceutical compositions for oral administration of insulin peptides
US20130065272A1 (en) * 2010-03-24 2013-03-14 Medical Research Council Synthesis of Site Specifically-Linked Ubiquitin
EP2380596A1 (en) 2010-04-20 2011-10-26 Technische Universität München Cyclopentapeptide derivatives and uses thereof
JP5725467B2 (ja) 2010-08-27 2015-05-27 国立大学法人 東京大学 新規人工翻訳合成系
JP5818237B2 (ja) * 2010-09-09 2015-11-18 国立大学法人 東京大学 N−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法
EP2647720B1 (en) 2010-12-03 2019-06-19 The University of Tokyo Peptide library production method, peptide library, and screening method
ES2586411T3 (es) 2011-03-04 2016-10-14 New York University Macrociclos sustitutos de enlace de hidrógeno como moduladores de Ras
US9133245B2 (en) 2011-06-13 2015-09-15 Trustees Of Boston College Cyclic lactadherin peptide mimetics and their uses
TWI640541B (zh) 2011-12-28 2018-11-11 中外製藥股份有限公司 Peptide compound having an annular portion and pharmaceutical composition thereof
GB201215538D0 (en) 2012-08-31 2012-10-17 Stetsenko Dmitry Method and compositions for removing acid-labile protecting groups
EP2897971B1 (en) 2012-09-24 2017-05-31 DSM Sinochem Pharmaceuticals Netherlands B.V. Method for producing a cyclic peptide
JP6440055B2 (ja) 2013-05-10 2018-12-19 国立大学法人 東京大学 ペプチドライブラリの製造方法、ペプチドライブラリ、及びスクリーニング方法
EP3030545B1 (en) 2013-08-05 2020-10-07 MedImmune Limited Amino acid derivatives
WO2015019999A1 (ja) 2013-08-05 2015-02-12 国立大学法人東京大学 荷電性非タンパク質性アミノ酸含有ペプチドの製造方法
JP6754997B2 (ja) 2013-08-26 2020-09-16 国立大学法人 東京大学 大環状ペプチド、その製造方法、及び大環状ペプチドライブラリを用いるスクリーニング方法
WO2015155676A1 (en) 2014-04-08 2015-10-15 Novartis Ag Novel aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
TW201622746A (zh) 2014-04-24 2016-07-01 諾華公司 改善或加速髖部骨折術後身體復原之方法
US10736932B2 (en) 2014-05-20 2020-08-11 Ohio State Innovation Foundation Small molecule Ras inhibitors
WO2015185162A1 (en) 2014-06-06 2015-12-10 Technische Universität München Modified cyclopentapeptides and uses thereof
EP3157508B1 (en) 2014-06-19 2020-12-09 Solural Pharma Aps Solid oral dosage form of lipophilic compounds
WO2016115168A1 (en) 2015-01-12 2016-07-21 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
US10815489B2 (en) 2015-03-13 2020-10-27 Chugai Seiyaku Kabushiki Kaisha Modified aminoacyl-tRNA synthetase and use thereof
CN107614689A (zh) 2015-03-27 2018-01-19 昆士兰大学 用于将非天然氨基酸并入蛋白质中的平台
JP2017043615A (ja) 2015-08-27 2017-03-02 塩野義製薬株式会社 環状ペプチドの膜透過性および/または代謝安定性を改善するシクロプロパンアミノ酸ユニット
EP3411413A4 (en) 2016-02-04 2019-09-18 The Johns Hopkins University SYNTHESIS AND COMPOSITION OF RAPAFUCINE LIBRARIES
WO2017150732A1 (ja) 2016-03-03 2017-09-08 中外製薬株式会社 チオール基をアミノ基近傍に有するアミノ酸をn末端に持つ非環状ペプチド-核酸複合体、そのライブラリー、およびそれから誘導される環状ペプチド-核酸複合体ライブラリーの製造方法
EP3442991A4 (en) 2016-04-15 2019-11-20 RA Pharmaceuticals, Inc. RAS-BINDING PEPTIDES AND METHODS OF USE
IT201600122363A1 (it) 2016-12-02 2018-06-02 Dolores Fregona Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi in oncologia
WO2018124162A1 (ja) 2016-12-28 2018-07-05 中外製薬株式会社 化合物の膜透過性を改善するための自己乳化型製剤
US12391971B2 (en) 2017-01-31 2025-08-19 Chugai Seiyaku Kabushiki Kaisha Method for synthesizing peptides in cell-free translation system
GB201702938D0 (en) 2017-02-23 2017-04-12 Univ Southampton Methods of generating and screening compartmentalised peptides libraries
US20200131669A1 (en) 2017-06-09 2020-04-30 Chugai Seiyaku Kabushiki Kaisha Cyclic peptide compound having high membrane permeability, and library containing same
KR20250007021A (ko) 2017-06-09 2025-01-13 추가이 세이야쿠 가부시키가이샤 N-치환 아미노산을 포함하는 펩타이드의 합성 방법
CN111479819B (zh) 2017-12-15 2024-06-14 中外制药株式会社 制备肽的方法和处理碱的方法
EP3878836B1 (en) 2018-11-07 2025-07-23 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
WO2020111238A1 (ja) 2018-11-30 2020-06-04 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
CN118184532A (zh) 2018-12-12 2024-06-14 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法
WO2020138336A1 (ja) 2018-12-26 2020-07-02 中外製薬株式会社 コドン拡張のための変異tRNA
CN113692401A (zh) 2019-03-15 2021-11-23 中外制药株式会社 芳香族氨基酸衍生物的制备方法
EP4056580A4 (en) 2019-11-07 2023-12-06 Chugai Seiyaku Kabushiki Kaisha METHOD FOR PRODUCING A PEPTIDE COMPOUND COMPRISING A STERICALLY HINDERED AMINO ACID
JP6880352B1 (ja) 2019-11-07 2021-06-02 中外製薬株式会社 Kras阻害作用を有する環状ペプチド化合物
WO2021117848A1 (ja) 2019-12-12 2021-06-17 中外製薬株式会社 非天然アミノ酸を含むペプチドの製造方法
KR20220121831A (ko) 2019-12-26 2022-09-01 추가이 세이야쿠 가부시키가이샤 번역용 조성물 및 펩타이드의 제조 방법
TWI873263B (zh) 2019-12-27 2025-02-21 日商中外製藥股份有限公司 胜肽化合物的合成法
TW202210498A (zh) 2020-06-03 2022-03-16 日商中外製藥股份有限公司 高難度序列之有效率的胜肽縮合法
JPWO2021261577A1 (da) 2020-06-25 2021-12-30
TW202229306A (zh) 2020-11-05 2022-08-01 日商中外製藥股份有限公司 抑制由二酮哌嗪形成所導致之缺陷的胜肽合成方法
TW202228654A (zh) 2020-12-22 2022-08-01 日商中外製藥股份有限公司 包含使用混合溶劑之冷凍乾燥步驟之醫藥品的製造方法
WO2022138891A1 (ja) 2020-12-25 2022-06-30 中外製薬株式会社 N-置換-アミノ酸残基を含むペプチド化合物の製造方法
CN116547295A (zh) 2020-12-28 2023-08-04 中外制药株式会社 氨基酸向固相合成用树脂的担载方法
KR102666765B1 (ko) 2021-05-07 2024-05-16 추가이 세이야쿠 가부시키가이샤 환상 펩타이드 화합물의 의약 용도
CN117279933A (zh) 2021-05-07 2023-12-22 中外制药株式会社 相对于hras和nras具有选择性kras抑制作用的环状化合物
AR125800A1 (es) 2021-05-07 2023-08-16 Chugai Pharmaceutical Co Ltd Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n
WO2022234639A1 (ja) 2021-05-07 2022-11-10 中外製薬株式会社 変異型ras(g12d)に対する選択的結合性を示す結合分子
EP4299069A4 (en) 2021-05-07 2025-03-05 Chugai Seiyaku Kabushiki Kaisha Preparation containing cyclic peptide compound and method for producing same
JPWO2023054636A1 (da) 2021-09-30 2023-04-06
KR20240070705A (ko) 2021-10-13 2024-05-21 추가이 세이야쿠 가부시키가이샤 펩타이드 화합물 및 계면활성제를 포함하는 조성물
KR102844018B1 (ko) 2021-12-28 2025-08-07 추가이 세이야쿠 가부시키가이샤 N-알킬 아미노산, 및 n-알킬 아미노산을 포함하는 펩타이드의 제조 방법
WO2023190283A1 (ja) 2022-03-28 2023-10-05 中外製薬株式会社 ポリオキシエチレン構造を含む油性成分を含有する化合物製剤
WO2023195516A1 (ja) 2022-04-08 2023-10-12 中外製薬株式会社 ペプチド化合物の製造方法
KR20250002095A (ko) 2022-05-02 2025-01-07 추가이 세이야쿠 가부시키가이샤 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물
KR20250006193A (ko) 2022-05-02 2025-01-10 추가이 세이야쿠 가부시키가이샤 디케토피페라진 형성에 의한 결손을 억제하는 펩티드 합성 방법
AU2023264918A1 (en) 2022-05-06 2025-01-09 Chugai Seiyaku Kabushiki Kaisha Cyclic compound having selective kras inhibitory effect on hras and nras
TW202430539A (zh) 2022-10-13 2024-08-01 日商中外製藥股份有限公司 包含n-取代胺基酸殘基的環狀胜肽化合物的製造方法

Also Published As

Publication number Publication date
TW202446781A (zh) 2024-12-01
US12415835B2 (en) 2025-09-16
US20150080549A1 (en) 2015-03-19
JP7297027B2 (ja) 2023-06-23
JP6961742B2 (ja) 2021-11-05
EP3974563A1 (en) 2022-03-30
TWI579296B (zh) 2017-04-21
JP2025186468A (ja) 2025-12-23
TW201720841A (zh) 2017-06-16
US20240166689A1 (en) 2024-05-23
EP2813512A1 (en) 2014-12-17
US20160311858A1 (en) 2016-10-27
JP2023123570A (ja) 2023-09-05
JPWO2013100132A1 (ja) 2015-05-11
TW201333029A (zh) 2013-08-16
JP2018118968A (ja) 2018-08-02
US20210061860A1 (en) 2021-03-04
TWI713889B (zh) 2020-12-21
US11891457B2 (en) 2024-02-06
JP7749619B2 (ja) 2025-10-06
EP2813512B1 (en) 2021-03-31
HUE054006T2 (hu) 2021-08-30
JP2022003092A (ja) 2022-01-11
JP6294080B2 (ja) 2018-03-14
TW202112802A (zh) 2021-04-01
TW201900670A (zh) 2019-01-01
US9409952B2 (en) 2016-08-09
TW202313654A (zh) 2023-04-01
WO2013100132A1 (ja) 2013-07-04
TWI640541B (zh) 2018-11-11
EP2813512A4 (en) 2016-02-10
JP2020109120A (ja) 2020-07-16
TWI852183B (zh) 2024-08-11
TWI787670B (zh) 2022-12-21

Similar Documents

Publication Publication Date Title
DK2788767T3 (da) Fremgangsmåde til detektering af nukleosomaddukter
DK2766392T3 (da) Fremgangsmåde til oprensning af antistoffer
DK3829175T3 (da) Fremgangsmåde til at konstruere fletningsliste
DK2768857T3 (da) Fremgangsmåder til oprensning af antistoffer
BR112014004902A2 (pt) peptídeos
DK2467204T3 (da) Fremgangsmåde til fremstilling af en sorbent
DK3760159T3 (da) Fremgangsmåde til udformning af en dental indretning
DK3125372T4 (da) Tilslutningsklemme
BR302012001035S1 (pt) Configuração aplicada a televisão
DK3104003T3 (da) Nacellekonstruktion til en vindmølle
DK2649101T3 (da) Fremgangsmåde til fremstilling af en tværbundet gel
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
EP2793943A4 (en) Anti-inflammatory non-ionized polyepipids
DK2582283T3 (da) Fremgangsmåde til estimering af en referencestilling
DK2671011T3 (da) Klemring
DK3985979T3 (da) Fremgangsmåde til bestemmelse af referenceenhed
DK3396980T3 (da) Binaural kompressor til opnåelse af retningsanvisninger
DK2701776T4 (da) Teknologi til samling af en dispenseringsgrænseflade
DK2511892T3 (da) Fremgangsmåde til detektering af en grænseoverskridelse
DK2751924T3 (da) Fremgangsmåde til regulering af et generatorsæt
DK2809782T3 (da) Forbedret fremgangsmåde til fremstilling af makrokugler
DK2607692T4 (da) Fremgangsmåde til bestemmelse af et spændingsbegrænsningsområde
ES1168758Y (es) Un accesorio de vertido
DK2616101T3 (da) Fremgangsmåde til oprensning af pegyleret erythropoietin
IL230669A0 (en) Hcv immunotherapy